• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CCR5Delta32 59537-G/A启动子多态性与低翻译效率及CCR5Delta32保护作用的丧失相关。

CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effects.

作者信息

Jin Qingwen, Agrawal Lokesh, Meyer L, Tubiana R, Theodorou Ioannis, Alkhatib Ghalib

机构信息

Department of Microbiology and Immunology, Indiana University School of Medicine, 635 Barnhill Drive, Rm. 420, Indianapolis, IN 46202, USA.

出版信息

J Virol. 2008 Mar;82(5):2418-26. doi: 10.1128/JVI.01596-07. Epub 2007 Dec 19.

DOI:10.1128/JVI.01596-07
PMID:18094161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2258923/
Abstract

We have recently demonstrated that the CCR5Delta32 protein interacts with CCR5 and CXCR4 and down-modulates their cell surface expression. We have also reported the absence of detectable expression of the truncated CCR5Delta32 protein in four out of six human immunodeficiency virus-infected (HIV(+)) CCR5(-/-) individuals. To explain the defect in protein expression in these samples, we cloned and sequenced the promoter regions of the six HIV(+) individuals. We have identified several polymorphisms in the CCR5Delta32 promoter region, but these polymorphisms were not associated with significant differences in mRNA levels. Coupled in vitro transcription/translation and polyribosome analysis demonstrated a strong association between a variant genotype designated CCR5Delta32 59537-A/A and a low translation efficiency. Protein analysis indicated that the peripheral blood mononuclear cells from two of the HIV(+) CCR5(-/-) individuals carrying the CCR5Delta32 59537-A/A variant expressed trace amounts of CCR5Delta32 protein compared to the individuals carrying the CCR5Delta32 59537-G/G genotype. The results imply that the absence of CCR5Delta32 protein in two HIV(+) individuals is due to a genetic defect in the translation of the protein. Together, these results highlight the importance of the CCR5Delta32 protein as an HIV suppressive factor and provide further insight into the mechanism of the protective effect of the CCR5Delta32 mutation.

摘要

我们最近证实,CCR5Delta32蛋白与CCR5和CXCR4相互作用,并下调它们在细胞表面的表达。我们还报告称,在6名感染人类免疫缺陷病毒(HIV(+))的CCR5(-/-)个体中,有4名未检测到截短的CCR5Delta32蛋白表达。为了解释这些样本中蛋白质表达的缺陷,我们对这6名HIV(+)个体的启动子区域进行了克隆和测序。我们在CCR5Delta32启动子区域发现了几种多态性,但这些多态性与mRNA水平的显著差异无关。体外转录/翻译偶联和多核糖体分析表明,一种名为CCR5Delta32 59537-A/A的变异基因型与低翻译效率之间存在密切关联。蛋白质分析表明,与携带CCR5Delta32 59537-G/G基因型的个体相比,两名携带CCR5Delta32 59537-A/A变异的HIV(+) CCR5(-/-)个体的外周血单核细胞表达的CCR5Delta32蛋白量极少。结果表明,两名HIV(+)个体中CCR5Delta32蛋白的缺失是由于该蛋白翻译过程中的遗传缺陷。总之,这些结果突出了CCR5Delta32蛋白作为一种HIV抑制因子的重要性,并为CCR5Delta32突变的保护作用机制提供了进一步的见解。

相似文献

1
CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effects.CCR5Delta32 59537-G/A启动子多态性与低翻译效率及CCR5Delta32保护作用的丧失相关。
J Virol. 2008 Mar;82(5):2418-26. doi: 10.1128/JVI.01596-07. Epub 2007 Dec 19.
2
CCR5Delta32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivo.CCR5Δ32蛋白的表达和稳定性对于体内抵抗1型人类免疫缺陷病毒至关重要。
J Virol. 2007 Aug;81(15):8041-9. doi: 10.1128/JVI.00068-07. Epub 2007 May 23.
3
CCR5Delta32 and promoter polymorphisms are not correlated with initial virological or immunological treatment response.CCR5Delta32及启动子多态性与初始病毒学或免疫学治疗反应无关。
AIDS. 2001 Nov 23;15(17):2259-66. doi: 10.1097/00002030-200111230-00007.
4
Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.CCR5Delta32蛋白在原代CD4+细胞对R5、R5X4和X4型1人类免疫缺陷病毒的抗性中的作用。
J Virol. 2004 Mar;78(5):2277-87. doi: 10.1128/jvi.78.5.2277-2287.2004.
5
Role of the genetic variant CCR5Δ32 in HBV infection and HBV/HIV co-infection.CCR5Δ32 基因变异在 HBV 感染和 HBV/HIV 合并感染中的作用。
Virus Res. 2020 Feb;277:197838. doi: 10.1016/j.virusres.2019.197838. Epub 2019 Dec 11.
6
Resistance to human immunodeficiency virus type 1 (HIV-1) generated by lentivirus vector-mediated delivery of the CCR5{Delta}32 gene despite detectable expression of the HIV-1 co-receptors.尽管可检测到HIV-1共受体的表达,但慢病毒载体介导的CCR5Δ32基因递送仍可产生对1型人类免疫缺陷病毒(HIV-1)的抗性。
J Gen Virol. 2008 Oct;89(Pt 10):2611-2621. doi: 10.1099/vir.0.2008/003624-0.
7
Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus.CCR5Delta32/CCR5Delta32基因型对血友病患者队列中人类免疫缺陷病毒感染发生率的保护作用有限,并对基因型X4病毒进行了选择。
J Infect Dis. 2003 Jan 15;187(2):215-25. doi: 10.1086/345881. Epub 2003 Jan 6.
8
Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32.ccr5delta32对CCR5介导的HIV-1感染的反式显性抑制机制
J Biol Chem. 1997 Dec 5;272(49):30603-6. doi: 10.1074/jbc.272.49.30603.
9
Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children.CCR5启动子区域的多态性影响围产期感染1型人类免疫缺陷病毒儿童的疾病进展。
J Infect Dis. 2001 Mar 1;183(5):814-8. doi: 10.1086/318828. Epub 2001 Jan 24.
10
Resistance to Human Immunodeficiency Virus 1 Infection Conferred by a Compound CCR5Δ32 and CCR5 C20S Heterozygote.CCR5Δ32 和 CCR5 C20S 杂合子赋予对人类免疫缺陷病毒 1 感染的抗性。
J Infect Dis. 2023 Jul 14;228(2):116-121. doi: 10.1093/infdis/jiad062.

引用本文的文献

1
Resistance to Human Immunodeficiency Virus 1 Infection Conferred by a Compound CCR5Δ32 and CCR5 C20S Heterozygote.CCR5Δ32 和 CCR5 C20S 杂合子赋予对人类免疫缺陷病毒 1 感染的抗性。
J Infect Dis. 2023 Jul 14;228(2):116-121. doi: 10.1093/infdis/jiad062.
2
Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient.HIV-1 包膜介导的融合水平较低与感染 CCR5-/-患者的长期存活有关。
AIDS. 2018 Oct 23;32(16):2269-2278. doi: 10.1097/QAD.0000000000001953.
3
C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection.C-C趋化因子受体5型(CCR5):控制HIV感染的一个新靶点。
Appl Transl Genom. 2013 May 26;2:3-16. doi: 10.1016/j.atg.2013.05.004. eCollection 2013 Dec 1.
4
The frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations.伊朗人群中CCR5启动子多态性和CCR5 Δ 32突变的频率。
Iran J Basic Med Sci. 2015 Apr;18(4):312-6.
5
Lack of Correlation Between the CCR5-Δ32 Mutation and Acute Myeloid Leukemia in Iranian Patients.伊朗患者中CCR5-Δ32突变与急性髓系白血病之间缺乏相关性。
Indian J Hematol Blood Transfus. 2015 Mar;31(1):29-31. doi: 10.1007/s12288-014-0408-y. Epub 2014 Jun 19.
6
Genetic and Epigenetic Regulation of CCR5 Transcription.CCR5 转录的遗传和表观遗传调控。
Biology (Basel). 2012 Dec 13;1(3):869-79. doi: 10.3390/biology1030869.
7
Is the CCR5 Δ 32 mutation associated with immune system-related diseases?CCR5Δ32 突变是否与免疫系统相关疾病有关?
Inflammation. 2013 Jun;36(3):633-42. doi: 10.1007/s10753-012-9585-8.
8
Effects of variant rs346473 in ARHGAP24 gene on disease progression of HBV infection in Han Chinese population.
J Huazhong Univ Sci Technolog Med Sci. 2011 Aug;31(4):482. doi: 10.1007/s11596-011-0477-1. Epub 2011 Aug 7.
9
The Consequence of a Founder Effect: CCR5-∆32, CCR2-64I and SDF1-3'A Polymorphism in Vlach Gypsy Population in Hungary.匈牙利弗拉赫吉普赛人群中的 CCR5-∆32、CCR2-64I 和 SDF1-3'A 多态性:一个奠基者效应的后果。
Pathol Oncol Res. 2012 Apr;18(2):177-82. doi: 10.1007/s12253-011-9425-4. Epub 2011 Jun 11.
10
The biology of CCR5 and CXCR4.CCR5和CXCR4的生物学特性。
Curr Opin HIV AIDS. 2009 Mar;4(2):96-103. doi: 10.1097/COH.0b013e328324bbec.

本文引用的文献

1
CCR5Delta32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivo.CCR5Δ32蛋白的表达和稳定性对于体内抵抗1型人类免疫缺陷病毒至关重要。
J Virol. 2007 Aug;81(15):8041-9. doi: 10.1128/JVI.00068-07. Epub 2007 May 23.
2
Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele.对来自两名CCR5δ32等位基因纯合个体的R5X4型人类免疫缺陷病毒1型包膜糖蛋白的遗传和功能分析。
J Virol. 2006 Apr;80(7):3684-91. doi: 10.1128/JVI.80.7.3684-3691.2006.
3
Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.CCR5基因Delta32杂合性与CCR5启动子多态性-2459 A/G对CCR5表达及对人类免疫缺陷病毒1型传播抗性的联合作用。
J Virol. 2005 Sep;79(18):11677-84. doi: 10.1128/JVI.79.18.11677-11684.2005.
4
Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.CCR5Delta32蛋白在原代CD4+细胞对R5、R5X4和X4型1人类免疫缺陷病毒的抗性中的作用。
J Virol. 2004 Mar;78(5):2277-87. doi: 10.1128/jvi.78.5.2277-2287.2004.
5
Emerging links between initiation of translation and human diseases.翻译起始与人类疾病之间的新联系。
Mamm Genome. 2002 Aug;13(8):401-10. doi: 10.1007/s00335-002-4002-5.
6
Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta 32 allele.
Lancet. 2002 May 25;359(9320):1832-4. doi: 10.1016/S0140-6736(02)08681-6.
7
A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Delta32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4.一名CCR5Δ32纯合感染个体的1型人类免疫缺陷病毒分离株通过CXCR4感染巨噬细胞和MT2细胞,表现出双嗜性。
J Virol. 2002 Apr;76(7):3114-24. doi: 10.1128/jvi.76.7.3114-3124.2002.
8
HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion.携带CCR5-Delta32/Delta32基因型个体的HIV-1感染:血清转化时获得合胞体诱导病毒。
J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):307-13. doi: 10.1097/00126334-200203010-00013.
9
Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration.CCR5Δ32杂合子中CCR5细胞表面表达降低是由基因剂量介导的,而非受体隔离。
J Biol Chem. 2002 Jan 18;277(3):2287-301. doi: 10.1074/jbc.M108321200. Epub 2001 Oct 16.
10
Determinants of the trans-dominant negative effect of truncated forms of the CCR5 chemokine receptor.CCR5趋化因子受体截短形式的反式显性负效应的决定因素。
J Biol Chem. 2001 Dec 14;276(50):46975-82. doi: 10.1074/jbc.M106432200. Epub 2001 Oct 12.